Neurogene (NGNE) Accumulated Depreciation (2013 - 2018)
Neurogene (NGNE) posted Accumulated Depreciation of $443000.0 for Q4 2018, down 17.2% on a QoQ basis from $535000.0 in Q4 2017, and down 17.2% year-over-year from $535000.0 in Q4 2017.
Neurogene (NGNE) Accumulated Depreciation (2013 - 2018) Analysis & Trends
Neurogene's Accumulated Depreciation history runs 6 years deep, the most recent figure standing at $443000.0 for Q4 2018.
- Quarterly Accumulated Depreciation fell 17.2% year-over-year to $443000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $443000.0 (down 17.2% YoY) and the FY2018 annual result came in at $443000.0, down 17.2% from the prior year.
- Accumulated Depreciation was $443000.0 for Q4 2018 at Neurogene, down from $535000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $535000.0 in Q4 2017 and bottomed at $90000.0 in Q4 2015.
- A 5-year average of $304000.0 and a median of $277000.0 in 2014 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2015 — Accumulated Depreciation sank 67.51% — and 2017, when it surged 205.71%.
- Neurogene's Accumulated Depreciation stood at $277000.0 in 2014, then sank by 67.51% to $90000.0 in 2015, then surged by 94.44% to $175000.0 in 2016, then jumped by 205.71% to $535000.0 in 2017, then fell by 17.2% to $443000.0 in 2018.
- Business Quant data shows NGNE's Accumulated Depreciation at $443000.0 in Q4 2018, $535000.0 in Q4 2017, and $175000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | Neurogene | 780.92 Mn | 780.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 443,000.00 |
| Dec 31, 2017 | 535,000.00 |
| Dec 31, 2016 | 175,000.00 |
| Dec 31, 2015 | 90,000.00 |
| Dec 31, 2014 | 277,000.00 |
| Dec 31, 2013 | 252,729.00 |